SCHEMBL30519124

SCHEMBL30519124

CC(C)(C)OC(=O)NCC(=O)N1CCc2ccc(Oc3ccc(C(F)(F)F)c(F)c3)cc2C1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ NR1H2 P55055 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.40
▸ ESR2 Q92731 2/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ DPP8 Q6V1X1 2/20 0.39
▸ DPP9 Q86TI2 2/20 0.39
▸ GHSR Q92847 3/20 0.38
▸ SIGMAR1 Q99720 1/20 0.38
▸ FNTA P49354 2/20 0.38
▸ FNTB P49356 2/20 0.38
▸ MMP1 P03956 1/20 0.38
▸ MMP9 P14780 1/20 0.38
▸ MMP13 P45452 1/20 0.38
▸ HTT P42858 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ THRB P10828 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25428445 1.00 ALDH1A1 (0.41) ALDH1A1L3MBTL1NR1H2HDAC8ESR2
SCHEMBL31566066 0.88 GHSR (0.49) ALDH1A1L3MBTL1NR1H2HDAC8ESR2
SCHEMBL25430398 0.88 L3MBTL1 (0.42) ALDH1A1L3MBTL1ESR2ESR1HTT
SCHEMBL31565972 0.87 L3MBTL1 (0.42) ALDH1A1L3MBTL1ESR2ESR1HTT
SCHEMBL30970511 0.85 NR1H2 (0.57) NR1H2ESR2ESR1GHSR
SCHEMBL27229601 0.85 NR1H2 (0.57) NR1H2ESR2ESR1GHSR
SCHEMBL31565856 0.85 L3MBTL1 (0.40) ALDH1A1L3MBTL1ESR2ESR1HTT
SCHEMBL31565827 0.84 L3MBTL1 (0.41) ALDH1A1L3MBTL1ESR2ESR1HTT
SCHEMBL25429983 0.83 NPC1 (0.42) ALDH1A1L3MBTL1ESR2ESR1HTT
SCHEMBL30519250 0.83 NPC1 (0.42) ALDH1A1L3MBTL1ESR2ESR1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129028-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2025-04-24 — — US disclosed
EP-4469036-A2 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2024-12-04 — — EP disclosed
WO-2023147063-A2 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR Opna Bio SA (CH) 2023-08-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250129028-A1 COMPOUNDS AND METHODS FOR YAP/TEAD MODULATION AND INDICATIONS THEREFOR YAP1, YES1, LATS1 ALDH1A1 2760/4885L3MBTL1 1076/4885NR1H2 174/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback